The β fibrinogen gene G-455-A polymorphism is a risk factor for Legg-Perthes disease

Journal of Thrombosis and Haemostasis

Volumn 1, Issue 11, 2003, Pages 2317-2321

  Dilley, A ^a   Hooper, W C ^a   Austin, H ^a,b   Jamil, M ^a,b   Miller, C ^a   Stokes, M ^b   Evatt, B ^a   Eldridge, J ^c  

^a NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^b EMORY UNIVERSITY   (United States)

^c University of Louisville School of Medicine   (United States)

Author keywords

Coagulation; Fibrinogen; Genetics; Legg Perthes disease

Indexed keywords

BBETA FIBRINOGEN; FIBRINOGEN;

ADOLESCENT; ADULT; ARTICLE; CASE CONTROL STUDY; CHILD; FEMALE; GENETICS; GENOTYPE; HUMAN; INDOOR AIR POLLUTION; LIFESTYLE; MALE; PERTHES DISEASE; PRESCHOOL CHILD; QUESTIONNAIRE; RISK; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; FIBRINOGEN; GENOTYPE; HUMANS; LEGG-PERTHES DISEASE; LIFE STYLE; MALE; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; QUESTIONNAIRES; RISK FACTORS; TOBACCO SMOKE POLLUTION;

EID: 4444230736     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1046/j.1538-7836.2003.00416.x     Document Type: Article

References (31)

1. Weinstein SL. Perthes Dis Current Orthopedics 1988; 2: 181-8.
2. Hering JA. Legg-Calve-Perthes Disease. Risemont IL: American Acad emy of Orthopedic Surgeons 1996, 10.
3. Glueck CJ, Glueck HI, Greenfield D, Freiberg R, Kahn A, Hamer T, Stroop D, Tracy T. Protein C and S deficiency, thrombophilia, and hypofibrinolysis: pathophysiologic causes of Legg-Perthes disease. Pediatr Res 1994; 35: 383-8.
4. Glueck CJ, Crawford A, Roy D, Frieberg R, Gleuck H, Stroop D. Association of antithrombotic factor deficiencies and hypofibrinolysis with Legg-Perthes disease. J Bone Joint Surg 1996; 78A: 3-13.
5. Glueck CJ, Brandt G, Gruppo R, Crawford A, Roy D, Tracy T, Stroop D, Wang P, Becker A. Resistance to activated protein C and Legg-Perthes disease, Clin Orthop 1997; 338: 139-52.
6. Thomas DP, Morgan G, Tayton K. Perthes disease and the relevance of thrombophilia. J Bone Joint Surg 1999; 81B: 691-5.
7. Hayek S, kenet G, Lubetski A, Rosenberg N, Gitel S, Weintroub S. Does thrombophilia play an aetiological role in Legg-Calve-Perthes disease. J Bone Joint Surg 1999; 338: 139-52.
8. Eldridge J, Dilley A, Austin H, El-Jamil M, Wolstein L, Doris J, Hooper WC, Meehan PL, Evatt B. The role of protein C, protein S, and resistance to activated protein C in Legg-Perthes disease. Pediatrics 2001; 107: 1329-34.
9. Gris JC, Schved JF, Brun S, Brunschwig C, Petris I, Lassonnery M, Martinez P, Sarlat C. Venous occlusion and chronic cigarette smoking: Dose dependent decrease in the measurable release of tissue-type plasminogen activator and von Willebrand factor. Atherosclerosis 1991; 91: 247-55.
10. Kimura S, Nishinaga M, Ozawa T, Shimada K. Thrombin generation as an acute effect of cigarette smoking. Am Heart J 1994; 128: 7-11.
11. Mercelina-Roumans PE, Ubachs JM, van Wersch JW. Coagulation and fibrinolysis in smoking and non-smoking pregnant women. BrJ Obstet Gynaecol 1996; 103: 789-94.
12. Glueck CJ, Freiberg RA, Crawford A, Gruppo R, Roy D, Tracy T, Sieve-Smith L, Wang P. Secondhand smoke, hypofibrinolysis, and Legg-Perthes disease, din Orthop 1998; 352d: 159-67.
13. Mata SG, Aicua EA, Ovejero AH, Grande MM. Legg-Calve-Perthes disease and passive smoking. J Pediatr Orthop 2000; 20: 326-30.
14. Tybjaerg-Hansen A, Algerholm-Larson B, Humphries SE, Abildgaard S, Schnohr P. A common mutation (G455IA) in the β-fibrinogen promotor is an independent predictor of plasma fibrinogen, but not of ischemic heart disease. J Clin Invest 1997; 99 (12): 3034-9.
15. Thomas AE, Green FR, Kelleher CH, Wilkes HC, Brennan PJ, Meade TW. Variation in the promotor region of the β fibrinogen gene is associated with plasma fibrinogen levels in smokers and non-smokers. Thromb Haemost 1991; 65: 487-90.
16. Green FR, Hamsten A, Blomback M, Humphries S. The role of β-fibrinogen genotype in determining plasma fibrinogen levels in young survivors of myocardial infarction and healthy controls from Sweden. Thromb Haemost 1993; 70: 915-20.
17. Behague I, Porier O, Nicaud V, Evans A. β-Fibrinogen gene polymorphisms are associated with plasma fibrinogen and coronary artery disease in patients with myocardial infarction (the ECTIM Study). Circulation 1996; 93: 440-9.
18. Wilhelmsen LK, Svardsudd K, Dorsan-Bengtsen B, Larsson B, Wekin L, Tibblin G. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med. 1984; 311: 501-5.
19. Meade TW, Mellows M, Brozovic GJ, Miller GJ, Chakrabarti RR, North WRS, Haines AP, Stirling Y, Imeson JD, Thompson SG. Haemostatic function and ischaemic heart disease: principal results of the North wick Park Heart Study. Lancet 1986; 2: 533-7.
20. Kannel WB, Wolf PA, Castelli WP, D'Agostino RB. Fibrinogen and risk of cardiovascular disease. The Framingham Study JAMA 1987; 258: 1183-6.
21. Koster T, Rosendaal FR, Reitsma PH, van der Velden PA, Briet E. Factor VII and fibrinogen levels as risk factors for venous thrombosis - a case-control study of plasma levels and DNA polymorphisms - the Leiden thrombophilia study (LETS). Thromb Haemost 1994; 71: 719-22.
22. Austin H, Hooper WC, Lally C, Dilley A, Ellingsen D, Wideman C, Wenger NK, Rawlins P, Silvia V, Evatt B. Venous thrombosis in relation to fibrinogen and factor VII genes among African-Americans. J Clin Epi 2000; 53: 997-1001.
23. Fowkes FGR, Conner JM, Smith FB, Wood J, Donnan PT, Lowe GDO. Fibrinogen genotype and risk of peripheral atherosclerosis. Lancet 1992; 339: 693-6.
24. Kleinbaum DG, Kupper LL, Muller KE. In: Applied Regression Analysis and Other Multivariate Methods. Boston, MA: PWS-KENT Publishing Co., 1986.
25. Rothman KJ. In: Modern Epidemiology. Boston, MA: Little Brown, 1986.
26. Mantel N. Chi-square tests with one degree of freedom: extensions of the Mantel-Haenszel procedure. J Am Stat Assoc 1963; 58: 690-700.
27. Breslow NE, Day NE. In: Statistical Methods in Cancer Research: 1. The Analysis of Case-Control Studies. Lyon: International Agency for Research on Cancer, 1980.
28. Fey GH, Fuller GM. Regulation of acute phase gene expression by inflammatory mediators. Mol Biol Med 1987; 4: 323-38.
29. Thomas AE, Green FR, Humphries SE. Association of the genetic variation at the β fibrinogen gene locus and plasma fibrinogen levels; interaction between allele frequency of the G/A-455 polymorphism, age and smoking. Clin Genet 1996; 50: 184-90.
30. Meade TW, Imeson J, Stirling Y. Effects of changes in smoking and other characteristics on clotting factors and risk of ischaemic heart disease. Lancet 1987; ii: 986-8.
31. Weinstein SL. Perthes disease. Curr Orthopedics 1988; 2: 181-8.